Carol Nolan (Offaly, Independent)

I wish to raise reimbursement support for continuous glucose monitoring sensors. The scheme is currently only available for people who have type 1 diabetes, so patients with type 2 diabetes are excluded. I am concerned at the increased volume of emails I receive on this issue from my constituents. In particular, I was alarmed by a case where a man was undergoing treatment for cancer who happened to be a type 2 diabetic. He applied to the medicines management programme in the HSE and went through the appeals mechanism but he was still refused. I find this very concerning, in particular as the patient was undergoing cancer treatment. At what point would a person's appeal be upheld to use this route? Could the system please be reviewed in the interests of fairness?

See this speech in context